Interestingly, we found that hepatic ERα expression levels were only significantly decreased in poorly controlled diabetic patients, which may be attributed to hyperinsulinemia-induced reprogramming of liver transcriptomics. The gene discussed is ESR1; the disease is hyperinsulinism.